Observational Study of Iron Metabolism in Anemia in ICU and Post-Operative Patients, Role of Hepcidin
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 153
- 试验地点
- 1
- 主要终点
- Functional iron deficiency
研究概览
简要总结
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation.
详细描述
Anemia in intensive care and post-operative patients is due to both blood loss (leading to iron loss) and inflammation. The latter is known to interfere with iron metabolism, inducing iron storage instead of using it for hemoglobin synthesis. The discover of a new regulatory hormone of iron metabolism, hepcidin, may help us to better understand the link between inflammation and iron functional deficit. The aim of our study is to observe the variation of usual iron metabolism biological markers and of hepcidin, in order to define the better marker of iron loss in these clinical situations.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 88 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Anemia (haemoglobin < 10 g/dL)
- •Hospitalization in ICU for an expected duration of 7 days or more
- •Or, day one post cardiac surgery
排除标准
- •Chronic anemia (Hb < 9 g/dL for more than one month before hospitalization)
- •Iron metabolism disease
结局指标
主要结局
Functional iron deficiency
时间窗: during the study
次要结局
- fatigue assessed by the MFI20 score for cardiac surgery patients(at one day,at seven days and at 28 days)
